Bayer AG (BAYRY) announced an update on their ongoing clinical study. Study Overview The PROGRESS-GT LOPD trial is an early-stage clinical study sponsored by AskBio, with Bayer as a collaborator, to ...

BERLIN--(BUSINESS WIRE)-- Bayer announced today progress for two potential therapies against Parkinson’s disease (PD). A first participant received randomized treatment in the pivotal Phase III ...

Genethon, a non-profit gene therapy R&D organization founded by the French Muscular Dystrophy Association (AFM-Telethon), began the new year with an R&D licensing deal for its gene therapy approach to ...

Trial results could underpin request for regulatory approval Bayer already working on manufacturing network Several other research teams working on similar treatments SAN SEBASTIAN, Spain, Sept 22 ...

First investigational allogeneic pluripotent stem cell derived therapy pivotal Phase III clinical trial exPDite-2 with bemdaneprocel started Phase II gene therapy trial REGENERATE-PD with AB-1005 ...